BioCryst Pharmaceuticals

Aktienkurs
6.55
Täglich Wechseln
0.25 3.97%
Monatlich
-7.62%
Jährlich
-27.14%
Q1 Prognose
4.65




Ebitda Veränderung Datum
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Chugai Pharma JPY 169.01B 12.52B 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
DBV Technologies USD -33.48M 5.55M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Incyte USD 506.92M 74.6M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Novavax USD -117.12M 55.66M 2024-09
PTC Therapeutics USD -33.11M 1B 2025-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


BioCryst Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.